119th Congress · introduced in the House · Mar 18, 2026
CLIMB Act
Official title from Congress.gov
Latest action (Mar 18, 2026): Referred to the House Committee on Financial Services.
View on Congress.govPolicy area: Finance and Financial Sector
No official summary has been published for this bill.
Includes amendment, cloture, and procedural votes. Each is labeled with its exact question; only a passage question is a vote to pass the bill.
No recorded roll calls on this bill in coverage.
Referred to the House Committee on Financial Services.
Introduced in House
Introduced in House
Actions from Congress.gov, newest first.
LD-2 reports whose issue descriptions explicitly cite this bill (bill type and number validated against Congress.gov records). A citation does not establish the client's position or any contact with a member.
Loading lobbying reportsCoverage: reports for 2025 onward, posted Jan 1, 2025 through Oct 20, 2026.
6 citations.
THE US CANNABIS ROUNDTABLE · lobbying firm or registrant: HOLLAND & KNIGHT LLP
2026 Q3 report (Jul 1, 2026 – Sep 30, 2026) · posted Oct 4, 2026 · issue area: Banking
$80,000
Paid to lobbying firm
H.R.9471 - SAFE Banking Act of 2026; H.R.7987 - Capital Lending and Investment for Marijuana Businesses Act (CLIMB Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE US CANNABIS ROUNDTABLE · lobbying firm or registrant: HOLLAND & KNIGHT LLP
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 8, 2026 · issue area: Banking
$80,000
Paid to lobbying firm
H.R.9471 - SAFE Banking Act of 2026; H.R.7987 - Capital Lending and Investment for Marijuana Businesses Act (CLIMB Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
CANNABIS FINNANCIAL INDUSTRY GROUP · lobbying firm or registrant: THE LIAISON GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 2, 2026 · issue area: Financial Institutions/Investments/Securities
Amount not reported
Cannabis banking for financial institutions including on the issue of debanking and the SAFE Banking Act (HR 9471) The CLIMB Act (HR 7987) related to access to capital for cannabis businesses.
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. View filing
UNITED STATES CANNABIS ROUNDTABLE · lobbying firm or registrant: THE LIAISON GROUP, LLC
2026 Q2 report (Apr 1, 2026 – Jun 30, 2026) · posted Jul 2, 2026 · issue area: Banking
$45,000
Paid to lobbying firm
…their own policies related to cannabis (2) allows for the safe banking (HR 9471) and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills include opposing HR 1447 the No Dedu…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
UNITED STATES CANNABIS ROUNDTABLE · lobbying firm or registrant: THE LIAISON GROUP, LLC
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted May 4, 2026 · issue area: Banking
$45,000
Paid to lobbying firm
…es to set their own policies related to cannabis (2) allows for the safe banking and access to capital for the state-regulated cannabis industry (The CLIMB Act HR 7987) (3) Advances aspect of cannabis research (4) ends needless arrests and incarceration for cannabis conduct. Specific bills today include opposing HR 1447 the N…
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing
THE US CANNABIS ROUNDTABLE · lobbying firm or registrant: HOLLAND & KNIGHT LLP
2026 Q1 report (Jan 1, 2026 – Mar 31, 2026) · posted Apr 17, 2026 · issue area: Banking
$80,000
Paid to lobbying firm
S.2860 - The Secure and Fair Enforcement Regulation Banking Act (SAFER Banking Act); H.R. 7987 - Capital Lending and Investment for Marijuana Businesses Act (CLIMB Act).
Congress inferred from the report year; bill number and the title cited with it match Congress.gov records, and the bill predates the report. The amount is lobbying spending for every issue on this report, not this bill alone, and none of it is paid to any member of Congress. View filing